This topic contains a solution. Click here to go to the answer

Author Question: The QRS vector appears downward in which of the following electrocardiogram leads? a. II c. aVL ... (Read 52 times)

leo leo

  • Hero Member
  • *****
  • Posts: 566
The QRS vector appears downward in which of the following electrocardiogram leads?
 
  a. II c. aVL
  b. V5 d. aVR

Question 2

Each millimeter on electrocardiographi c recording paper represents _____ seconds.
 
  a. 0.02 c. 0.20
  b. 0.04 d. 0.40



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

joanwhite

  • Sr. Member
  • ****
  • Posts: 308
Answer to Question 1

ANS: D
The QRS vector will normally be upward in leads I, II, aVL, and V5 and is usually downward in leads aVR and V1.

Answer to Question 2

ANS: B
Time is recorded on the x-axis, with each millimeter representing 0.04 second.




leo leo

  • Member
  • Posts: 566
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


yeungji

  • Member
  • Posts: 319
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

The U.S. Preventive Services Task Force recommends that all women age 65 years of age or older should be screened with bone densitometry.

Did you know?

Giardia is one of the most common intestinal parasites worldwide, and infects up to 20% of the world population, mostly in poorer countries with inadequate sanitation. Infections are most common in children, though chronic Giardia is more common in adults.

Did you know?

Persons who overdose with cardiac glycosides have a better chance of overall survival if they can survive the first 24 hours after the overdose.

Did you know?

Patients who have undergone chemotherapy for the treatment of cancer often complain of a lack of mental focus; memory loss; and a general diminution in abilities such as multitasking, attention span, and general mental agility.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library